AU2093499A - Members of tnf and tnfr families - Google Patents

Members of tnf and tnfr families

Info

Publication number
AU2093499A
AU2093499A AU20934/99A AU2093499A AU2093499A AU 2093499 A AU2093499 A AU 2093499A AU 20934/99 A AU20934/99 A AU 20934/99A AU 2093499 A AU2093499 A AU 2093499A AU 2093499 A AU2093499 A AU 2093499A
Authority
AU
Australia
Prior art keywords
tnf
members
tnfr families
tnfr
families
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20934/99A
Inventor
Altaf Kassam
George Lamson
David Pot
Catherine Tribouley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU2093499A publication Critical patent/AU2093499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU20934/99A 1997-12-30 1998-12-22 Members of tnf and tnfr families Abandoned AU2093499A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6895997P 1997-12-30 1997-12-30
US60068959 1997-12-30
US21227098A 1998-12-16 1998-12-16
US09212270 1998-12-16
PCT/US1998/027474 WO1999033980A2 (en) 1997-12-30 1998-12-22 Members of tnf and tnfr families

Publications (1)

Publication Number Publication Date
AU2093499A true AU2093499A (en) 1999-07-19

Family

ID=26749548

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20934/99A Abandoned AU2093499A (en) 1997-12-30 1998-12-22 Members of tnf and tnfr families

Country Status (2)

Country Link
AU (1) AU2093499A (en)
WO (1) WO1999033980A2 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US6689579B1 (en) 1996-10-25 2004-02-10 Human Genome Sciences, Inc. Polynucleotides encoding neutrokine-α
CA2277925A1 (en) 1997-01-14 1998-07-16 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6.alpha. and 6.beta.
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
ES2286856T3 (en) 1997-09-12 2007-12-01 Biogen Idec Ma Inc. TRAIN RICH RECEIVERS IN CISTEINA.
US6297367B1 (en) * 1997-12-30 2001-10-02 Chiron Corporation Polynucleotide encoding TNFL1
EP1053351A4 (en) * 1998-01-27 2002-09-25 Millennium Pharm Inc Novel molecules of the tnf receptor superfamily and uses therefor
HUP0105283A3 (en) 1999-01-25 2004-08-30 Biogen Idec Ma Inc Cambridge Baff, inhibitors thereof and their use in the modulation of b-cell response
US20030095967A1 (en) 1999-01-25 2003-05-22 Mackay Fabienne BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
US6475986B1 (en) * 1999-02-02 2002-11-05 Research Development Foundation Uses of THANK, a TNF homologue that activates apoptosis
AU2574200A (en) * 1999-02-19 2000-09-04 Toshio Kitamura Novel tnf receptor-like proteins
JP2003526330A (en) * 1999-02-23 2003-09-09 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド Neutrokine-α and Neutrokine-α splice variants
US20030022233A1 (en) 1999-04-30 2003-01-30 Raymond G. Goodwin Methods of use of the taci/taci-l interaction
PL211786B1 (en) 1999-08-17 2012-06-29 Apoxis Sa Application of an antibody and a polypeptide
UA74798C2 (en) 1999-10-06 2006-02-15 Байоджен Айдек Ма Інк. Method for treating cancer in mammals using polypeptide interfering with interaction between april and its receptors
ATE511857T1 (en) 2000-02-16 2011-06-15 Genentech Inc ANTI-APRIL MONOCLONAL ANTIBODIES AND THEIR USE IN THE TREATMENT OF IMMUNE DISEASES OR CANCER
NZ521540A (en) 2000-04-11 2004-09-24 Genentech Inc Multivalent antibodies and uses therefor
US20020086018A1 (en) 2000-05-12 2002-07-04 Theill Lars Eyde Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI
US7220840B2 (en) 2000-06-16 2007-05-22 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator protein
ES2609016T3 (en) 2000-06-16 2017-04-18 Human Genome Sciences, Inc. Antibodies that bind immunospecifically to BLyS
WO2002009755A2 (en) 2000-07-27 2002-02-07 Genentech, Inc. Apo-2l receptor agonist and cpt-11 synergism
US20030091565A1 (en) 2000-08-18 2003-05-15 Beltzer James P. Binding polypeptides and methods based thereon
UA83458C2 (en) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. The isolated polypeptide baff-r (the receptor of the factor of activation of b-cells of the family tnf)
US7019012B2 (en) 2000-12-20 2006-03-28 Boehringer Ingelheim International Pharma Gmbh & Co. Kg Quinazoline derivatives and pharmaceutical compositions containing them
JP2004537290A (en) 2001-05-24 2004-12-16 ヒューマン　ジノーム　サイエンシーズ，　インコーポレイテッド Antibodies to tumor necrosis factor δ (APRIL)
EP1409544B1 (en) 2001-07-03 2009-06-17 Genentech, Inc. Human dr4 antibodies and uses thereof
DE10221018A1 (en) 2002-05-11 2003-11-27 Boehringer Ingelheim Pharma Use of inhibitors of EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) / prostatic hypertrophy
AU2004233164B2 (en) 2003-03-28 2009-10-08 Biogen Ma Inc. Truncated BAFF receptors
KR20060027801A (en) 2003-06-05 2006-03-28 제넨테크, 인크. Combination therapy for b cell disorders
EP1709072A1 (en) 2004-01-29 2006-10-11 Genentech, Inc. Variants of the extracellular domain of bcma and uses thereof
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
CA2576193A1 (en) 2004-08-03 2006-02-16 Biogen Idec Ma Inc. Taj in neuronal function
BRPI0516297A (en) 2004-10-05 2008-09-02 Genentech Inc Vasculitis treatment methods and articles of manufacture
WO2006067210A1 (en) 2004-12-23 2006-06-29 Laboratoires Serono S.A. Bcma polypeptides and uses thereof
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
EP3173084B1 (en) 2005-11-11 2019-10-23 Boehringer Ingelheim International GmbH Quinazoline derivatives for the treatment of cancer diseases
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
AU2006318539B2 (en) 2005-11-23 2012-09-13 Genentech, Inc. Methods and compositions related to B cell assays
WO2007123765A2 (en) 2006-03-31 2007-11-01 Human Genome Sciences Inc. Neutrokine-alpha and neutrokine-alpha splice variant
PT2068880E (en) 2006-09-18 2012-07-12 Boehringer Ingelheim Int Method for treating cancer harboring egfr mutations
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
PT2451445T (en) 2009-07-06 2019-07-10 Boehringer Ingelheim Int Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
CN102597268B (en) 2009-09-03 2017-09-22 弗·哈夫曼-拉罗切有限公司 For treat, diagnose and monitoring rheumatoid arthritis method
WO2011109280A1 (en) 2010-03-05 2011-09-09 Lerner Research Institute Methods and compositions to treat immune-mediated disorders
WO2012118750A2 (en) 2011-02-28 2012-09-07 Genentech, Inc. Biological markers and methods for predicting response to b-cell antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE254135T1 (en) * 1996-03-14 2003-11-15 Human Genome Sciences Inc HUMAN TUMOR NECROSIS FACTOR DELTA AND EPSILON
DK0939804T4 (en) * 1996-10-25 2011-07-18 Human Genome Sciences Inc Neutrokine-alpha
WO1998027114A2 (en) * 1996-12-17 1998-06-25 Schering Corporation Mammalian cell surface antigens; related reagents
CA2232743A1 (en) * 1997-04-02 1998-10-02 Smithkline Beecham Corporation A tnf homologue, tl5
WO1998055620A1 (en) * 1997-06-06 1998-12-10 Regeneron Pharmaceuticals, Inc. Ntn-2 member of tnf ligand family
CA2292835A1 (en) * 1997-06-06 1998-12-10 Regeneron Pharmaceuticals, Inc. Ntn-2 member of tnf ligand family
AU9376498A (en) * 1997-09-05 1999-03-22 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
EA200000311A1 (en) * 1997-09-12 2000-10-30 Апотек Р Энд Д Са NEW PROTEIN IMMUNE SYSTEM - KAU

Also Published As

Publication number Publication date
WO1999033980A3 (en) 1999-11-18
WO1999033980A9 (en) 1999-10-14
WO1999033980A2 (en) 1999-07-08

Similar Documents

Publication Publication Date Title
AU2093499A (en) Members of tnf and tnfr families
AU4074100A (en) New members of tnf and tnfr families
AU7464998A (en) Melanocortin receptor ligands and methods of using same
AU7710198A (en) Single pass lead and method of use
AU9790198A (en) Compounds and methods
AU9319598A (en) Low density polymers and methods of making and using same
AU1616499A (en) Chemokine variants and methods of use
AU4266596A (en) Composition and use
AU7223998A (en) Polymers and their preparation
AU6695398A (en) Immunoadhesins and methods of production and use thereof
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU2682895A (en) EG Cells of Ungulates
AU3118297A (en) Sok-1 and methods of use
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU6884298A (en) Viral obesity methods and compositions
AU2021597A (en) Size-sorting trawl and method of using same
AU2408397A (en) Ob protein receptor genes and use of the same
AU7525496A (en) Methods and compositions comprising glut-2 and glut-2 chimeras
AU2003204844A1 (en) Use of methylnaltrexone and related compounds
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
AU8074698A (en) (costal2) genes and their uses
AU7135598A (en) Synthesis and use of biased arrays
AU2584699A (en) Immediate early genes and methods of use therefor
IL118404A0 (en) Enzyme degrading rhamnogalacturonane II its preparation and use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase